Hamps Bio board approves remuneration hike for directors and KMPs

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Board approved remuneration hikes for CMD Herrik Mountbaton Shah and WTD Shrenikkumar Mountkumar Shah
  • CFO Mitali Shrenikkumar Shah also received an approved increase in pay
  • Remuneration for Director Pallavi Herrik Shah was approved by the board
  • Decisions were based on Nomination and Remuneration committee recommendations
  • Meeting held on September 9, 2026, complied with SEBI Listing Regulations
powered bylight_fuzz_icon
50518967

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited board of directors approved remuneration increases for its Chairman and Managing Director, Whole Time Director, Chief Financial Officer, and a director during a meeting held on September 9, 2026. The decisions were made based on recommendations from the Nomination and Remuneration committee.

The corporate governance move affects key leadership roles within the Gujarat-based chemical manufacturer. The board meeting commenced at 5:00 pm and concluded at 5:45 pm at the company's corporate office.

Remuneration Approvals

The board considered and approved the following changes to executive compensation:

  • Increase in remuneration for Mr. Herrik Mountbaton Shah, Chairman and Managing Director (DIN: 01052316)
  • Increase in remuneration for Mr. Shrenikkumar Mountkumar Shah, Whole Time Director (DIN: 00973690)
  • Increase in remuneration for Mrs. Mitali Shrenikkumar Shah, Chief Financial Officer
  • Approval of remuneration for Mrs. Pallavi Herrik Shah, Director (DIN: 10418931)

All approvals followed recommendations received from the Nomination and Remuneration committee.

Regulatory Disclosure

The company issued this disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ravi Baheti, Company Secretary & Compliance Officer.

Hamps Bio operates manufacturing units in Ankleshwar and Surat, Gujarat.

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-1.54%0.0%0.0%0.0%0.0%

How will the increased executive compensation impact Hamps Bio's net profit margins in the upcoming fiscal quarters?

Are there any pending performance-linked incentives or bonus structures tied to these remuneration increases for the key leadership roles?

What is the market's reaction to this governance decision, and has there been any notable movement in Hamps Bio's stock price following the disclosure?

Hamps Bio adopts FY26 financials, approves registered office shift

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Hamps Bio Limited adopted its audited FY26 standalone and consolidated financial statements
  • Shareholders approved shifting the registered office within Gujarat under the same ROC jurisdiction
  • Pallavi Herrik Shah was reappointed as director after retiring by rotation
  • The 19th AGM was held in Ankleshwar on September 9, 2026, with remote e-voting enabled
powered bylight_fuzz_icon
50504716

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited concluded its 19th Annual General Meeting on September 9, 2026. Shareholders approved the adoption of audited standalone and consolidated financial statements for FY26 and authorized the shifting of the company’s registered office within Gujarat.

The meeting, held at the company’s registered office in Ankleshwar, Gujarat, began at 12:00 pm and concluded at 1:00 pm. Herrik Mountbaton Shah, Managing Director and Chairman, presided over the proceedings. The Board appointed Richa Goyal & Associates as the scrutinizer for the voting process.

Key Resolutions Passed

Shareholders transacted all businesses mentioned in the notice dated August 12, 2026. The ordinary business included:

  • Adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with reports from the Board of Directors and auditors.
  • Reappointment of Pallavi Herrik Shah as a director, who retired by rotation and offered herself for reappointment.

Under special business, members approved the shift of the registered office from one city to another within the same state of Gujarat. The move remains under the jurisdiction of the Registrar of Companies, Ahmedabad.

Attendance and Governance

The following directors attended the meeting:

Name Designation
Herrik Mountbaton Shah Managing Director and Chairman
Shrenikkumar Mountkumar Shah Whole-time Director
Pallavi Herrik Shah Director
Jinay Dipakkumar Palrecha Independent Director

Shivali Rajpurohit, Independent Director, was granted leave of absence due to personal reasons. Ravi Baheti served as Company Secretary and Compliance Officer, while Mitali Shrenik Shah acted as Chief Financial Officer.

Voting Process

The company facilitated remote e-voting through Bigshare Services Private Limited between September 6 and September 8, 2026. Eligible shareholders who did not vote electronically could cast ballot papers at the meeting venue. The voting results will be communicated to the stock exchanges and published on the company’s website.

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-1.54%0.0%0.0%0.0%0.0%

How might the relocation of Hamps Bio's registered office within Gujarat impact its operational logistics or local regulatory compliance costs?

What strategic initiatives is the board planning for FY27 following the approval of FY26 financials and the reappointment of key directors?

Will the shift in registered office address any specific operational inefficiencies or provide tax advantages within the Ahmedabad jurisdiction?

More News on Hamps Bio

1 Year Returns:0.00%